Decentralized studies are becoming increasingly common as a result of COVID-19. Will this trend continue? Join Darshan Kulkarni as he talks with guests Kelly Willenberg and Geoffrey Schick about the challenges presented by decentralized studies, and why this new way of conducting studies might not be ideal. Plus, we’ll discuss what the future clinical trial patient may look like.
A discussion with CRO CEO John Reites. Our discussion will explore decentralized clinical trials, the missing secret ingredient in clinical...
A discussion with health and clinical trial entrepreneur Zedrick Buhay on starting a clinical trial site, choosing studies and therapeutic...
A discussion on Project Management/Clinical Monitoring/Clinical Operations including on Clinical Development Training, recruitment and...
